Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Is Breast Cancer Curable? Miraculous News
Is Breast Cancer Curable? Miraculous News 4

Is breast cancer curable in 2026? Read miraculous news about new drugs and the powerful treatments that lead to amazing recovery stories.

Getting a breast cancer diagnosis can feel scary. But, it’s good to know many cases can be cured, if caught early.

Recent data shows the 5-year survival rate for breast cancer in the U.S. is about 91-92%. This big jump in survival rates comes from better early detection and new treatments.

How curable breast cancer is depends on when it’s found and other personal factors. We’ll look into what affects curability and the newest treatment options.

Key Takeaways

  • Early detection significantly improves breast cancer survival rates.
  • The 5-year relative survival rate for breast cancer in the U.S. is approximately 91-92%.
  • Breast cancer curability depends on the stage at diagnosis and individual factors.
  • Modern treatments have revolutionized breast cancer outcomes.
  • Advancements in treatment options continue to improve survival rates.

Understanding Breast Cancer and Its Curability

To understand if breast cancer can be fully cured, we need to know what “cure” and “remission” mean in cancer treatment. These terms are often mixed up, but they have different meanings. It’s important for patients and doctors to understand them.

What Defines a “Cure” in Cancer Treatment

A “cure” in cancer treatment means no cancer cells are left, making the patient cancer-free. Early detection and effective treatment are key to a cure. We’ll look at what makes a cure possible, like the cancer type and stage, and the success of treatments and cures for breast cancer.

The idea of a cure is linked to long-term survival. Thanks to new medical tech and treatments, more breast cancer patients are surviving. But, the path to a cure is different for everyone.

The Concept of Remission vs. Cure

Remission means the cancer is controlled, and there are no symptoms. But, it’s not the same as a cure. A patient in remission might see the cancer come back. We’ll talk about the differences between remission and cure, and what they mean for breast cancer patients in terms of is breast cancer treatable and full recovery chances.

It’s key to understand the difference between remission and cure to manage hopes and make treatment choices. By looking at the latest research and practices, we can better understand what it means to be cured of breast cancer and what affects curability.

Is Breast Cancer Curable? The Short Answer

Is Breast Cancer Curable? Miraculous News
Is Breast Cancer Curable? Miraculous News 5

To understand if breast cancer is curable, we need to look at the disease itself and how well treatments work. We’ll give a quick answer on if breast cancer can be cured. We’ll also talk about how early detection helps.

Defining Curability in the Context of Breast Cancer

Being curable means the disease can be completely removed, leaving the patient cancer-free. This depends on when the cancer is found and what kind it is.

Breast cancer can be very different from one person to another. Things like how big the tumor is, if it’s in the lymph nodes, and if it has spread all play a part in if it can be cured.

The Role of Early Detection in Curability

Finding breast cancer early can greatly improve survival chances. Research shows that catching it early makes treatment more likely to work.

New screening tools like mammograms and ultrasound help find cancer sooner. This leads to better results for people with stage I cancer compared to those found later.

Survival Rates by Stage at Diagnosis

Stage at Diagnosis

5-Year Survival Rate

Stage 0

99%

Stage I

99%

Stage II

85-90%

Stage III

60-70%

Stage IV

27%

The table shows how survival rates change based on when cancer is found. It clearly shows the value of catching it early in making it curable.

Breast Cancer Survival Statistics in the United States

Is Breast Cancer Curable? Miraculous News
Is Breast Cancer Curable? Miraculous News 6

Recent data shows a hopeful trend for breast cancer survival in the U.S. Early detection is key for both patients and doctors. It helps in making the right treatment choices.

5-Year Survival Rates by Stage

The 5-year survival rate is a key measure of breast cancer treatment success. For breast cancer caught early, the survival rate is almost 100%. This means most women diagnosed early can survive.

For cancer that has spread to nearby areas, the survival rate is about 87%. But, if the cancer has spread far, the rate drops to around 32%. These numbers show how vital early detection is.

Early detection makes a big difference in survival chances. It shows the need for quick and effective treatments.

Stage at Diagnosis

5-Year Relative Survival Rate

Localized

Nearly 100%

Regional

About 87%

Distant Metastatic

Around 32%

Long-term Survival: 10-Year and 15-Year Rates

Looking at long-term survival rates gives us a fuller picture. The Breast Cancer Research Foundation data shows hopeful trends, mainly for early-stage diagnoses.

Women with early-stage breast cancer have a much better chance of long-term survival. This highlights the critical role of early detection and treatment.

As we keep improving in breast cancer research and treatment, understanding these survival rates is key. It helps us find ways to improve and tailor care for patients.

Curability by Breast Cancer Stage

Knowing the stage of breast cancer is key to finding the best treatment. The stage affects the treatment choice and success chances.

Stage 0 (Ductal Carcinoma In Situ)

Stage 0, or ductal carcinoma in situ (DCIS), means cancer cells are in ducts but haven’t spread. It’s non-invasive and very treatable. Treatments include lumpectomy followed by radiation therapy or mastectomy. The survival rate for DCIS is nearly 100% with proper treatment.

Stage I Breast Cancer

Stage I breast cancer is split into IA and IB. IA has tumors 2 cm or less without lymph node involvement. IB has tumors 2 cm or less with lymph node involvement. Treatments include surgery, radiation therapy, and chemotherapy. The survival rate for Stage I is about 99%.

Stage II Breast Cancer

Stage II is split into IIA and IIB. IIA has larger tumors or lymph node involvement. IIB has tumors over 5 cm or a few nearby lymph nodes. Treatments include surgery, chemotherapy, radiation therapy, and hormonal therapy. Survival rates for Stage II range from 85% to 93%.

Stage III Breast Cancer

Stage III is locally advanced and split into IIIA, IIIB, and IIIC. It involves larger tumors or more lymph node involvement. Treatments include chemotherapy, surgery, and radiation therapy. Sometimes, targeted therapy is used. Survival rates for Stage III vary from 55% to 72%.

In summary, breast cancer curability greatly depends on the stage. Early stages have much better survival rates. Knowing the stage and treatment options is vital for the best outcome.

Metastatic Breast Cancer: Can Stage IV Be Cured?

When someone is diagnosed with metastatic breast cancer, they often wonder if they can be cured. Stage IV breast cancer is usually not curable. But, thanks to new treatments, many patients live longer and better lives.

Current Treatment Approaches for Metastatic Disease

Treatment for metastatic breast cancer is tailored to each patient. It depends on the cancer’s type, the patient’s health, and past treatments. Today, treatments include targeted therapy, chemotherapy, hormone therapy, and immunotherapy. These are often combined for the best results.

  • Targeted therapy attacks specific cancer molecules.
  • Chemotherapy kills cancer cells, used when cancer spreads a lot.
  • Hormone therapy works for hormone-positive cancers, slowing them down.
  • Immunotherapy uses the immune system to fight cancer.

A top breast cancer doctor, says, “The treatment for metastatic breast cancer is getting better, giving patients and their families new hope.”

“The goal of treatment is not just to extend life, but to improve its quality, enabling patients to live fully despite their diagnosis.”

Living with Metastatic Breast Cancer as a Chronic Disease

Thanks to new treatments, metastatic breast cancer is now seen as a chronic condition. This means a more detailed care plan, including regular check-ups, symptom management, and support for patients and their families.

Managing metastatic breast cancer well includes:

  1. Regular check-ups with the healthcare team to keep an eye on the disease and adjust treatments.
  2. Managing symptoms to keep quality of life high, like pain control and handling treatment side effects.
  3. Emotional and psychological support, because a chronic diagnosis affects mental health.

By taking a whole-person approach to care, people with metastatic breast cancer can live full and meaningful lives. Research and clinical trials keep finding new ways to treat the disease, giving hope for better futures.

Factors Affecting Breast Cancer Curability

Breast cancer curability depends on many factors. These include biological and demographic elements. Knowing these factors helps in creating better treatment plans and improving patient results.

Cancer Subtypes and Genetics

The type and genetics of breast cancer greatly affect its curability. Breast cancer is divided into subtypes based on receptors like estrogen and progesterone. These subtypes have different treatment responses.

For example, hormone receptor-positive (HR+) breast cancer has a better outlook than triple-negative breast cancer (TNBC). Genetic mutations, like BRCA1 and BRCA2, also affect how aggressive the cancer is and how well it responds to treatment.

Age, Race, and Access to Care

Demographic factors like age, race, and healthcare access also play a big role. Younger patients often face more aggressive cancer types, while older patients may have other health issues that make treatment harder. Racial disparities are also a concern, with African American women facing more aggressive cancers and worse outcomes than white women.

“The disparities in breast cancer outcomes among different racial and ethnic groups are a significant concern, highlighting the need for targeted interventions to improve access to care and reduce healthcare inequities.”

Getting timely and right care is key to improving breast cancer outcomes. Those with less access to healthcare may face delays in diagnosis and treatment, leading to worse results. It’s important to work on these disparities to help all populations with breast cancer.

Treatment Modalities That Improve Curability

Breast cancer treatment has seen big improvements thanks to new therapies. These include surgery, radiation, chemotherapy, and more. These advancements have greatly helped patients.

Surgery Options and Their Impact on Cure Rates

Surgery is key in treating breast cancer. It can cure many patients. The choice of surgery affects how well a patient does.

Breast-conserving surgery and radiation have similar survival rates to mastectomy for early-stage cancer. The right surgery depends on the cancer and the patient’s wishes.

Radiation Therapy’s Role in Preventing Recurrence

Radiation therapy is vital after surgery. It kills cancer cells left behind. This lowers the chance of cancer coming back.

New radiation methods like intensity-modulated radiation therapy (IMRT) and proton therapy are more precise. They protect healthy tissues better.

Chemotherapy and Hormonal Therapy

Chemotherapy and hormonal therapy target cancer cells everywhere in the body. Chemotherapy is best for aggressive cancers. Hormonal therapy works for cancers that grow in response to hormones.

Targeted Therapies and Immunotherapies

Targeted and immunotherapies are new and promising. They are less harsh and more effective. For example, HER2-targeted therapies help HER2-positive cancer patients a lot.

These treatments work by targeting specific cancer proteins. Immunotherapies use the body’s immune system to fight cancer. They are being tested for different types of breast cancer.

Using all these treatments together can make breast cancer more curable. The right treatment depends on the cancer and the patient’s health and wishes.

The Importance of Multidisciplinary Care in Breast Cancer Treatment

Breast cancer is complex, needing a team of experts for treatment. This team approach ensures patients get care that fits their needs perfectly.

The Breast Cancer Treatment Team

A team of specialists works together to treat breast cancer. This team includes surgeons, medical oncologists, and more. Each plays a key role in helping patients.

  • Surgeons remove tumors and affected tissue.
  • Medical Oncologists give chemotherapy and other treatments.
  • Radiation Oncologists use radiation to kill cancer cells.
  • Radiologists read scans to find and stage cancer.
  • Pathologists check tissue samples for diagnosis and details.
  • Nurses offer support, teach patients, and manage side effects.

Coordinated Care Approaches and Their Benefits

Coordinated care means the team works together to create a treatment plan. This teamwork leads to better health, happier patients, and more efficient care.

Benefits

Description

Improved Patient Outcomes

Effective management of treatment leads to better health.

Enhanced Patient Satisfaction

Patients are happier when they get care from a united team.

More Efficient Care

Streamlined care reduces unnecessary treatments and steps.

Recurrence Risk: What It Means for “Cure”

Breast cancer recurrence risk is a big deal in treatment success. After treatment, the chance of cancer coming back worries everyone. Knowing this risk helps manage hopes and make care plans.

Understanding Local vs. Distant Recurrence

Breast cancer can come back in two ways: local and distant. Local recurrence is when cancer shows up again in the same breast or chest wall. Distant recurrence, or metastasis, means cancer spreads to other places like bones, liver, or lungs.

It’s key to know the difference. Local recurrence might need surgery or radiation. Distant recurrence often calls for chemotherapy or targeted therapy.

Monitoring and Managing Recurrence Risk

Managing recurrence risk means watching closely, taking steps to prevent it, and sometimes using more treatments. Regular check-ups and tests like mammograms help catch recurrence early.

Many things affect recurrence risk. These include the cancer’s stage and type, how well the first treatment worked, and the patient’s health. Doctors use this info to plan follow-up care that fits each patient’s risk.

Risk Factor

Description

Impact on Recurrence Risk

Cancer Stage at Diagnosis

The extent of cancer spread at the time of diagnosis.

Higher stages are associated with increased recurrence risk.

Cancer Subtype

The biological characteristics of the cancer.

Certain subtypes, like triple-negative, have different recurrence risks.

Effectiveness of Initial Treatment

How well the initial treatment worked.

Successful initial treatment reduces recurrence risk.

By watching patients closely and adjusting care plans, doctors can help outcomes. This helps lower the chance of cancer coming back.

Breakthrough Advancements Improving Breast Cancer Curability

Breakthroughs in early detection and precision medicine are changing breast cancer care. We see big steps forward in treatment, from new detection tools to targeted therapies. These changes are making treatments better and improving patients’ lives.

Innovations in Early Detection Technologies

Early detection is key to beating breast cancer. New tools include:

  • Advanced imaging like 3D mammography and breast MRI
  • Artificial intelligence (AI) to help doctors diagnose better
  • Genetic tests for those at high risk

These tools help doctors find cancer early, when it’s easier to treat.

Precision Medicine and Targeted Therapies

Precision medicine is changing how we treat breast cancer. It lets us tailor treatments to each tumor’s genetic makeup. This makes treatments more effective and with fewer side effects.

Examples include:

  • HER2-targeted therapies for HER2-positive cancers
  • Hormone therapies for hormone receptor-positive cancers
  • PARP inhibitors for BRCA1 and BRCA2 mutation carriers

Promising Clinical Trials and Research Directions

Current clinical trials are exploring new ways to fight breast cancer. They include:

  • Immunotherapies that boost the immune system
  • Nano-particle treatments that target cancer cells
  • Combination therapies that mix different treatments

These studies could lead to even better treatments for breast cancer.

Treatment Aspect

Traditional Approach

Modern Approach

Early Detection

Mammography

3D Mammography, Breast MRI, AI-assisted diagnosis

Treatment Planning

One-size-fits-all

Precision medicine, genetic profiling

Therapies

Chemotherapy, surgery, radiation

Targeted therapies, immunotherapies, combination therapies

Addressing Disparities in Breast Cancer Outcomes

Despite progress in treating breast cancer, there are big gaps in outcomes. These gaps are seen more in people with lower incomes and different races. These gaps affect how well care is given and how long people live after being diagnosed.

Socioeconomic and Racial Factors Affecting Treatment Access

Money and race are big factors in breast cancer outcomes. Women from lower socioeconomic backgrounds often struggle to get the care they need. This is because of lack of insurance, trouble getting to doctors, and not knowing about screenings.

Racial gaps also play a big role. For example, African American women often die more from breast cancer than white women.

The reasons for these gaps are complex:

  • Not enough access to healthcare
  • Delays in finding out about cancer because of not getting screened
  • Different types of tumors in different racial and ethnic groups
  • Money issues affecting how well people stick to treatment plans

Initiatives to Improve Equity in Breast Cancer Care

To fix these gaps, many efforts are underway. Community-based programs help spread the word and teach about breast cancer screening. Also, patient navigation programs help people get past barriers to getting diagnosed and treated on time.

Other efforts include:

  1. Changing policies to cover more healthcare
  2. Special programs to get more screenings in areas that need them most
  3. Studying why there are differences in breast cancer in different groups

By tackling the reasons behind these gaps, we can work towards fairer care. This will help improve survival rates for everyone. 

Life After Breast Cancer Treatment

Life after breast cancer treatment is more than just getting better physically. It’s also about emotional and mental healing. Survivors face many challenges that need support and care.

Long-term Monitoring and Follow-up Care

After treatment, patients need to watch for any signs of cancer coming back. Regular check-ups with doctors are key to catching problems early. These visits help keep an eye on health and solve any issues quickly.

These follow-up visits include:

  • Physical examinations
  • Mammograms or other imaging tests as recommended by the healthcare team
  • Discussions about any symptoms or side effects experienced

Monitoring also helps manage risks of new cancers and treatment side effects. We help patients create a care plan that fits their needs.

Physical Recovery and Managing Side Effects

Getting better physically is a big part of life after treatment. Survivors might feel tired, have pain, or deal with lymphedema and body image changes. We guide them on how to handle these issues.

Some ways to manage side effects include:

  1. Doing regular exercise that fits their abilities
  2. Using pain management like medicine or other therapies
  3. Wearing compression garments or aids for lymphedema

We also stress the importance of good nutrition and lifestyle choices. These help support health and well-being during recovery.

Emotional and Psychological Aspects of Survivorship

The emotional and mental journey after treatment is just as vital as physical recovery. Survivors might feel many emotions, like relief, anxiety, and fear of cancer coming back. We know they need emotional support.

Support can come from:

  • Counseling or therapy for emotional issues
  • Support groups, online or in-person, to connect with others
  • Mindfulness and stress-reduction techniques for mental health

By focusing on emotional and mental health, we help survivors smoothly move into their new life after treatment.

Conclusion: The Future of Breast Cancer Curability

Breast cancer curability is shaped by early detection, treatment, and patient factors. Research keeps pushing the boundaries, leading to better patient results.

New technologies and precision medicine are changing breast cancer treatment. Targeted and immunotherapies are making treatments more effective and tailored to each patient.

Investing in breast cancer research is key to improving survival rates. By learning more about the disease and creating new treatments, we can improve patient lives. The future of breast cancer care looks promising, with a focus on teamwork and patient-centered care.

FAQ

Can breast cancer be cured?

Yes, breast cancer can be cured if caught early. The cure rate depends on the cancer’s stage and type, and how well the treatment works.

What is the breast cancer cure rate?

The cure rate for breast cancer changes with the stage at diagnosis. For Stage 0 and Stage I, the cure rate is high, with survival rates from 90% to 100% over 5 years.

Is breast cancer treatable?

Yes, breast cancer can be treated. The treatment plan depends on the cancer’s stage, type, and the patient’s health.

What are the most treatable cancers?

Breast cancer is very treatable, mainly when found early. Other cancers that are treatable include testicular cancer, thyroid cancer, and some lymphomas.

What are the treatment options for breast cancer?

Treatments for breast cancer include surgery, radiation, chemotherapy, and more. These are often used together.

What is the survival rate for breast cancer?

In the U.S., the 5-year survival rate for breast cancer is about 90%. Survival rates are higher for cancers found early.

Can Stage IV breast cancer be cured?

Curing Stage IV (metastatic) breast cancer is rare. But, treatment can manage the disease, ease symptoms, and improve life quality. New research and treatments offer hope for better outcomes.

How does early detection impact breast cancer curability?

Finding breast cancer early greatly increases the chance of a cure. Mammograms and other screening tools help find cancers early, leading to better outcomes.

What factors affect breast cancer curability?

Several factors influence breast cancer curability. These include the cancer’s stage and type, genetics, and the patient’s age, race, and healthcare access.

What is the role of a multidisciplinary team in breast cancer treatment?

A team of healthcare experts is key in treating breast cancer. They include surgeons, oncologists, and others. Their coordinated care improves treatment results.

How can recurrence risk be managed?

To manage recurrence risk, watch for signs, follow care plans, and sometimes use preventive treatments like hormonal therapy.

What are the latest advancements in breast cancer treatment?

New advancements in breast cancer treatment include better early detection, precision medicine, and targeted therapies. These offer hope for better outcomes.

How can disparities in breast cancer outcomes be addressed?

To address disparities, we need to improve equity in breast cancer care. This includes making screening and treatment more accessible, mainly for those who are underserved.

What are the challenges after completing breast cancer treatment?

After treatment, patients face challenges like managing side effects and dealing with emotional and psychological aspects of survivorship. They also need to navigate long-term follow-up care.

References

Breast Cancer Research Foundation (BCRF): https://www.bcrf.org/about-breast-cancer/breast-cancer-survival-rates/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91